Morphosp. z o.o.

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2010-10-11
Share capital
20,000.00 PLN
Registered address
Hlonda 10/12 u, 02-972 Warszawa, Poland
Electronic delivery address
AE:PL-25659-94976-RIAGJ-12

Financials

Revenue history (in k)

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 145 days for 2021).

  • 202524/07/2026
  • 202421/06/2025
  • 202316/04/2024
  • 202220/09/2023
  • 202107/12/2022
  • 202028/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 262.09kMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 42.12kMedianUSD 20.66kAverageUSD 86.62k
Operating costs
This companyUSD 202.51kMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 370.11kMedianUSD 544.32kAverageUSD 1.76m

Authorized Representatives

Radosław Daniel Kutyba – President of the Management Board

Manner of representation

Each member of the management board acting independently is authorized to make declarations of will concerning the company's property rights and obligations and to sign on behalf of the company.

Ownership

OwnerSharesShare valueStake
Edyta Katarzyna Gutowska Kutybaage 46
100$1,350.6225%
Radosław Daniel Kutybaage 46
300$4,051.8675%

Radosław Daniel Kutyba and Edyta Katarzyna Gutowska Kutyba hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2010-12-20.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 143.5K

Public aid

9 public aid cases recorded, with a total value of $17,013.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$2,606
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$1,346
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$434

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Cosmedicasp. z o.o.
DR ZdrowieS.A.
MagmaxS.A.
Novopharm - Millersp. j.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Nukloversp. z o.o.
Massmedsp. z o.o.
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.
Femaherbsp. z o.o.

FAQ

Last updated: 2026-07-24